AZGP1 and type 2 diabetes mellitus: The mapped proteins of these N-glycopeptides are known to be involved in platelet degranulation, protein activation cascade, peptidase inhibitor activity, and complement activation, some of which have been identified as potential biomarkers for T1D or T2D, including AZGP1, CLU, C2, C4, F2, KNG1, and SERPING1 (Zhang et al., 2013; Das and Kamalden, 2014).